コーア商事 HD（9273）のセグメントごとの売上高・利益等
セグメント通期
- 【有報】
- セグメント情報等、連結財務諸表
| 科目 | 年度 | 原薬販売事業 | 医薬品製造販売事業 |
|---|---|---|---|
| 売上高 | 2016/06 | 114億 | 38.4億 |
| 2017/06 | 114億 +0.5% | 36.9億 -3.9% | |
| 2018/06 | 113億 -1% | 35億 -5.3% | |
| 2019/06 | 109億 -4% | 43.3億 +23.8% | |
| 2020/06 | 103億 -5.2% | 57.2億 +32.1% | |
| 2021/06 | 108億 +4.6% | 70.2億 +22.8% | |
| 2022/06 | 128億 +19% | 75.1億 +6.9% | |
| 2023/06 | 142億 +10.2% | 78.9億 +5.1% | |
| 2024/06 | 137億 -3% | 84億 +6.5% | |
| 2025/06 | 146億 +6.3% | 86.7億 +3.2% | |
| 科目 | 年度 | 原薬販売事業 | 医薬品製造販売事業 |
| 営業利益 | 2016/06 | 15.4億 | 1.47億 |
| 2017/06 | 19.1億 +23.9% | -3.4億 赤字 | |
| 2018/06 | 16.1億 -15.5% | -3.25億 赤字 | |
| 2019/06 | 16.1億 ±-0% | -3.32億 赤字 | |
| 2020/06 | 19.1億 +18.6% | 4.53億 | |
| 2021/06 | 22.4億 +17.4% | 12億 +165% | |
| 2022/06 | 23.9億 +6.6% | 14.2億 +18.5% | |
| 2023/06 | 27.3億 +14.1% | 15.3億 +7.9% | |
| 2024/06 | 27.7億 +1.5% | 17億 +10.8% | |
| 2025/06 | 32.2億 +16.1% | 21.4億 +25.7% | |
| 科目 | 年度 | 原薬販売事業 | 医薬品製造販売事業 |
| 営業利益率 | 2016/06 | 13.5% | 3.8% |
| 2017/06 | 16.7% +3.2% | -9.2% 赤字 | |
| 2018/06 | 14.2% -2.5% | -9.3% 赤字 | |
| 2019/06 | 14.8% +0.6% | -7.7% 赤字 | |
| 2020/06 | 18.5% +3.7% | 7.9% | |
| 2021/06 | 20.8% +2.3% | 17.1% +9.2% | |
| 2022/06 | 18.6% -2.2% | 18.9% +1.8% | |
| 2023/06 | 19.3% +0.7% | 19.4% +0.5% | |
| 2024/06 | 20.2% +0.9% | 20.2% +0.8% | |
| 2025/06 | 22% +1.8% | 24.7% +4.5% | |
| 科目 | 年度 | 原薬販売事業 | 医薬品製造販売事業 |
| 設備投資額 | 2016/06 | - | - |
| 2017/06 | - | - | |
| 2018/06 | - | - | |
| 2019/06 | 8.5百万 | 6.32億 | |
| 2020/06 | 88百万 +940.6% | 0.55億 -91.3% | |
| 2021/06 | 62百万 -29.6% | 2.71億 +395.9% | |
| 2022/06 | 34百万 -44.8% | 3.53億 +30% | |
| 2023/06 | 50百万 +46.9% | 3.6億 +2.2% | |
| 2024/06 | 444百万 +779.9% | 9.04億 +150.9% | |
| 2025/06 | 71百万 -84.1% | 30億 +232.3% | |
| 科目 | 年度 | 原薬販売事業 | 医薬品製造販売事業 |
| 固定資産増加額 | 2016/06 | 24百万 | 14.8億 |
| 2017/06 | 29百万 +20.3% | 19.8億 +34.5% | |
| 2018/06 | 25百万 -14.2% | 11.1億 -44.3% | |
| 2019/06 | 8.5百万 -66.2% | 6.32億 -42.8% | |
| 2020/06 | 88百万 +940.6% | 0.55億 -91.3% | |
| 2021/06 | 62百万 -29.6% | 2.71億 +395.9% | |
| 2022/06 | 34百万 -44.8% | 3.53億 +30% | |
| 2023/06 | 50百万 +46.9% | 3.6億 +2.2% | |
| 2024/06 | 444百万 +779.9% | 9.04億 +150.9% | |
| 2025/06 | 71百万 -84.1% | 30億 +232.3% | |
| 科目 | 年度 | 原薬販売事業 | 医薬品製造販売事業 |
| 従業員数 | 2016/06 | - | - |
| 2017/06 | - | - | |
| 2018/06 | - | - | |
| 2019/06 | 82 | 211 | |
| 2020/06 | 81 -1.2% | 195 -7.6% | |
| 2021/06 | 80 -1.2% | 201 +3.1% | |
| 2022/06 | 77 -3.8% | 204 +1.5% | |
| 2023/06 | 76 -1.3% | 200 -2% | |
| 2024/06 | 76 ±0% | 194 -3% | |
| 2025/06 | 75 -1.3% | 208 +7.2% | |
| 科目 | 年度 | 原薬販売事業 | 医薬品製造販売事業 |
| 平均臨時雇用人員 | 2016/06 | - | - |
| 2017/06 | - | - | |
| 2018/06 | - | - | |
| 2019/06 | 9 | 18 | |
| 2020/06 | 7 -22.2% | 14 -22.2% | |
| 2021/06 | 10 +42.9% | 26 +85.7% | |
| 2022/06 | 8 -20% | 32 +23.1% | |
| 2023/06 | 10 +25% | 43 +34.4% | |
| 2024/06 | 9 -10% | 64 +48.8% | |
| 2025/06 | 8 -11.1% | 67 +4.7% | |
| 科目 | 年度 | 原薬販売事業 | 医薬品製造販売事業 |
| 資産 | 2016/06 | 105億 | 58.2億 |
| 2017/06 | 111億 +5.3% | 79.8億 +37.2% | |
| 2018/06 | 123億 +11.4% | 87.8億 +9.9% | |
| 2019/06 | 122億 -1.1% | 96.4億 +9.8% | |
| 2020/06 | 128億 +5% | 104億 +7.4% | |
| 2021/06 | 143億 +11.9% | 101億 -2% | |
| 2022/06 | 154億 +7.9% | 107億 +5.4% | |
| 2023/06 | 168億 +8.7% | 112億 +4.3% | |
| 2024/06 | 180億 +7% | 120億 +7.5% | |
| 2025/06 | 195億 +8.6% | 154億 +28.2% |
セグメント四半期
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
|---|---|---|---|---|---|---|
| 原薬販売事業 | ||||||
| 売上高 1Q2Q 3Q | 2018/06 | - | - | - | 33.1億 | 113億 |
| 2019/06 | 21.4億 | 25.8億 | 26.7億 | 34.8億 +5.1% | 109億 -4% | |
| 2020/06 | 20.1億 -6.1% | 28.5億 +10.4% | 22.8億 -14.8% | 31.8億 -8.7% | 103億 -5.2% | |
| 2021/06 | 25.7億 +27.9% | 27.1億 -4.7% | 24.9億 +9.3% | 30.2億 -5% | 108億 +4.6% | |
| 2022/06 | 31億 +20.3% | 33.7億 +24.2% | 29.5億 +18.4% | 34.3億 +13.8% | 128億 +19% | |
| 2023/06 | 34.7億 +11.9% | 37.1億 +10% | 30億 +1.9% | 39.9億 +16.1% | 142億 +10.2% | |
| 2024/06 | 35.9億 +3.7% | 34.2億 -7.8% | 32.6億 +8.6% | 34.6億 -13.2% | 137億 -3% | |
| 営業利益 1Q2Q 3Q | 2018/06 | - | - | - | 4.91億 | 16.1億 |
| 2019/06 | 2.64億 | 3.97億 | 3.66億 | 5.83億 +18.7% | 16.1億 ±-0% | |
| 2020/06 | 3億 +13.4% | 5.88億 +48.2% | 4.06億 +10.8% | 6.16億 +5.7% | 19.1億 +18.6% | |
| 2021/06 | 5.35億 +78.4% | 5.83億 -0.9% | 5.52億 +36.1% | 5.72億 -7.1% | 22.4億 +17.4% | |
| 2022/06 | 6.09億 +13.9% | 6.76億 +16.1% | 5.01億 -9.3% | 6.04億 +5.5% | 23.9億 +6.6% | |
| 2023/06 | 6.72億 +10.4% | 7.05億 +4.2% | 6.49億 +29.6% | 7.01億 +16.2% | 27.3億 +14.1% | |
| 2024/06 | 6.86億 +2.1% | 7.13億 +1.2% | 6.94億 +6.9% | 6.76億 -3.6% | 27.7億 +1.5% | |
| 営業利益率 | 2018/06 | - | - | - | 14.8% | 14.2% |
| 2019/06 | 12.3% | 15.4% | 13.7% | 16.7% +1.9% | 14.8% +0.6% | |
| 2020/06 | 14.9% +2.6% | 20.7% +5.3% | 17.8% +4.1% | 19.4% +2.7% | 18.5% +3.7% | |
| 2021/06 | 20.8% +5.9% | 21.5% +0.8% | 22.2% +4.4% | 19% -0.4% | 20.8% +2.3% | |
| 2022/06 | 19.7% -1.1% | 20.1% -1.4% | 17% -5.2% | 17.6% -1.4% | 18.6% -2.2% | |
| 2023/06 | 19.4% -0.3% | 19% -1.1% | 21.6% +4.6% | 17.6% ±0% | 19.3% +0.7% | |
| 2024/06 | 19.1% -0.3% | 20.9% +1.9% | 21.3% -0.3% | 19.5% +1.9% | 20.2% +0.9% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 医薬品製造販売事業 | ||||||
| 売上高 1Q2Q 3Q | 2018/06 | - | - | - | 10.2億 | 35億 |
| 2019/06 | 10.2億 | 10億 | 9.5億 | 13.6億 +33.7% | 43.3億 +23.8% | |
| 2020/06 | 8.69億 -14.5% | 16.3億 +63% | 14.7億 +54.4% | 17.5億 +28.6% | 57.2億 +32.1% | |
| 2021/06 | 15億 +72.6% | 17.7億 +8.5% | 18億 +22.9% | 19.5億 +11.3% | 70.2億 +22.8% | |
| 2022/06 | 17.5億 +16.6% | 21.4億 +20.8% | 17.3億 -3.7% | 18.8億 -3.4% | 75.1億 +6.9% | |
| 2023/06 | 18.9億 +8.3% | 21億 -1.8% | 19.9億 +14.6% | 19.1億 +1.3% | 78.9億 +5.1% | |
| 2024/06 | 22.3億 +17.8% | 21.4億 +1.9% | 21.3億 +6.9% | 19億 -0.3% | 84億 +6.5% | |
| 営業利益 1Q2Q 3Q | 2018/06 | - | - | - | -1.14億 | -3.25億 |
| 2019/06 | -0.91億 | -1.61億 | -1.19億 赤字 | 0.39億 | -3.32億 赤字 | |
| 2020/06 | -1.37億 赤字 | 2億 | 1.67億 | 2.23億 +470.9% | 4.53億 | |
| 2021/06 | 1.53億 | 3.31億 +65.6% | 3.91億 +134.7% | 3.24億 +45.3% | 12億 +165% | |
| 2022/06 | 2.62億 +71.1% | 6億 +81.2% | 3.63億 -7.4% | 1.96億 -39.4% | 14.2億 +18.5% | |
| 2023/06 | 3.37億 +28.5% | 4.24億 -29.4% | 4.73億 +30.5% | 3億 +52.6% | 15.3億 +7.9% | |
| 2024/06 | 5.26億 +55.9% | 5.06億 +19.4% | 4.54億 -4% | 2.14億 -28.5% | 17億 +10.8% | |
| 営業利益率 | 2018/06 | - | - | - | -11.2% | -9.3% |
| 2019/06 | -8.9% | -16.1% | -12.5% 赤字 | 2.9% | -7.7% 赤字 | |
| 2020/06 | -15.8% 赤字 | 12.2% | 11.4% | 12.7% +9.8% | 7.9% | |
| 2021/06 | 10.2% | 18.7% +6.5% | 21.7% +10.3% | 16.6% +3.9% | 17.1% +9.2% | |
| 2022/06 | 15% +4.8% | 28% +9.3% | 20.9% -0.8% | 10.4% -6.2% | 18.9% +1.8% | |
| 2023/06 | 17.8% +2.8% | 20.2% -7.8% | 23.8% +2.9% | 15.7% +5.3% | 19.4% +0.5% | |
| 2024/06 | 23.6% +5.8% | 23.6% +3.4% | 21.4% -2.4% | 11.3% -4.4% | 20.2% +0.8% | |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
